Chaudhary Waleed Tariq¹, Ammar Ahmed Butt², Syed Aizaz Khalid³, Hasham Qureshi⁴, Shariqa Farhath Mohammed5, Daniyal Ahmed6*

¹Junior Clinical fellow Plastic Surgery, Countess of Chester Hospital
²Post Graduate Trainee Medicine, DHQ Teaching Hospital, Mirpur
³Lecturer, Federal Medical College, Islamabad
⁴Training Medical Officer/ Post Graduate Training Medical Officer, Ayub Teaching Hospital, Abbottabad, Pakistan
⁵Junior Training Fellow, Royal stoke University Hospital, Stoke-on-Trent, UK
⁶Health Services Academy, Al-Nafees Medical College and Hospital, Islamabad, Pakistan

*Corresponding Author: Daniyal Ahmed, Health Services Academy, Al-Nafees Medical College and Hospital, Islamabad, Pakistan.

Received: April 08, 2024; Published: May 07, 2024

Abstract

Background: The most successful method of reversible contraception is long-acting reversible contraception (LARC). Most women are pleased with LARC techniques, however spotting and unexpected bleeding are typical causes for discontent and abandoning the treatment altogether. Hormonal birth control implants such as Implanon, Norplant, and Nexplanon, as well as the hormonal intrauterine devices (IUDs) Paragard and Mirena, are also considered LARCs.

Objective: To determine the level of awareness and factors that affect the use of LARCs among female health care professionals

Methodology: From June 1st, 2022, to June 30th, 2022, researchers in Twin Cities, Pakistan surveyed 130 reproductive-age female health care employees at five different healthcare institutions using a cross-sectional methodology. By use of a lottery system, participants were chosen at random. The chosen individuals completed a questionnaire. SPSS v23 was used to input and evaluate the data.

Results: A sample size of 130 (N) was collected in which 30 were doctors, 50 were para-medical staff and 50 were from nursing. Level of awareness was about 80% while believe in myths was about 60% of our selected participants. False believes and intentions towards LARCs is more than the other contraceptive methods.

Conclusion: Current acceptance of LARC among health professionals of reproductive age is 60%. LARC adoption was completely dominated by short-term family planning methods. Factors such as age of respondents, attitude of spouse or partner, discussion with spouse or partner, and use of LARC before the study were statistically significant and associated with LARC adoption.

Keywords: LARCs; Health Care Female Workers; Pakistan; Contraceptives

References

1. Sully EA., et al. “Adding it up: investing in sexual and reproductive health” (2019).
2. Ganatra B., et al. “Global, regional, and subregional classification of abortions by safety, 2010–14: estimates from a Bayesian hierarchical model”. The Lancet10110 (2017): 2372-2381.
3. Bellizzi S., et al. “Reasons for discontinuation of contraception among women with a current unintended pregnancy in 36 low and middle-income countries”. Contraception1 (2020): 26-33.
4. Uganda National Council for Science and Technology. National guidelines for research involving humans as research participants. Uganda National Council for Science and Technology Kampala-Uganda (2014).
5. Jambola ET., et al. “Early resumption of sexual intercourse and its associated factors among postpartum women in Western Ethiopia: a cross-sectional study”. International Journal of Women's Health 6 (2020): 381-91.
6. New WHO tool helps guide contraception choices following childbirth. Sexual and reproductive health (2016).
7. Sharrow D., et al. “Global, regional, and national trends in under-5 mortality between 1990 and 2019 with scenario-based projections until 2030: a systematic analysis by the UN Inter-agency Group for Child Mortality Estimation”. The Lancet Global Health2 (2022): e195-206.
8. Hug L., et al. “Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment”. The Lancet 10302 (2021): 772-785.
9. Madden T., et al. “Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design”. Contraception3 (2009): 196-201.
10. Cleland J. “The complex relationship between contraception and abortion”. Best Practice and Research Clinical Obstetrics and Gynaecology 62 (2020): 90-100.
11. Brooks N., et al. “USA aid policy and induced abortion in sub-Saharan Africa: an analysis of the Mexico City Policy”. The Lancet Global Health8 (2019): e1046-e1053.
12. Anguzu R., et al. “High parity predicts use of long-acting reversible contraceptives in the extended postpartum period among women in rural Uganda”. Contraception and Reproductive Medicine1 (2018): 1-7.
13. Ajayi AI., et al. “Unplanned pregnancy-risks and use of emergency contraception: a survey of two Nigerian Universities”. BMC Health Services Research1 (2017): 1-8.
14. Oduyebo T., et al. “Factors associated with postpartum use of long-acting reversible contraception”. American Journal of Obstetrics and Gynecology 1 (2019): 43-e51.
15. Gipson JD., et al. “The effects of unintended pregnancy on infant, child, and parental health: a review of the literature”. Studies in Family Planning1 (2018): 18-38.
16. Jain A and Tobey E. “New Client‐Centered Discontinuation Measures Using the Demographic and Health Survey Calendar Data”. Studies in Family Planning (2022).
17. Bradley SE., et al. “Global contraceptive failure rates: who is most at risk?” Studies in Family Planning1 (2019): 3-24.
18. Senderowicz L. “Contraceptive autonomy: conceptions and measurement of a novel family planning indicator”. Studies in Family Planning2 (2020): 161-176.
19. Mann ES., et al. “Patients' experiences with South Carolina's immediate postpartum Long-acting reversible contraception Medicaid policy”. Contraception2 (2019): 165-171.
20. Festin MP. “Overview of modern contraception”. Best Practice and Research Clinical Obstetrics and Gynaecology 66 (2020): 4-14.
21. Ranjit N., et al. “Contraceptive failure in the first two years of use: differences across socioeconomic subgroups”. Family planning perspectives (2001): 19-27.
22. Bellizzi S., et al. “The impact of underuse of modern methods of contraception among adolescents with unintended pregnancies in 12 low-and middle-income countries”. Journal of Global Health2 (2019).
23. Hossain MB and Phillips JF. “The impact of outreach on the continuity of contraceptive use in rural Bangladesh”. Studies in Family Planning 1 (1996): 98-106.
24. Casterline JB., et al. “Unmet need and unintended fertility: longitudinal evidence from Upper Egypt”. International Family Planning Perspectives (2013): 158-166.
25. Barden-O’Fallon JL., et al. “Association between contraceptive 382 discontinuation and pregnancy intentions in Guatemala”. Revista Panamericana de Salud Pública 6 (2008): 410-417.
26. Slaymaker E., et al. “Trends in sexual activity and demand for and use of modern contraceptive methods in 74 countries: a retrospective analysis of nationally representative surveys”. The Lancet Global Health4 (2020): e567-579.
27. Gormley R., et al. “Comparing options for females seeking permanent contraception in high resource countries: a systematic review”. Reproductive Health 18 (2021): 1-8.
28. “Trends in contraceptive use Worldwide 2015”. Contraception (2015).
29. Sarfraz M., et al. “Role of social network in decision making for increasing uptake and continuing use of long acting reversible (LARC) methods in Pakistan”. Reproductive Health1 (2021): 1-1.
30. Beyene D., et al. “LEVEL AND FACTORS ASSOCIATED WITH THE USE OF LONG-ACTING REVERSIBLE CONTRACEPTIVE METHODS AMONG MARRIED WOMEN IN SHONE TOWN ADMINISTRATION, HADIYA ZONE, SOUTHERN ETHIOPIA”. Ethiopian Journal of Reproductive Health2 (2019): 9.
31. Aregay W., et al. “Utilization of long-acting reversible contraceptive methods and associated factors among female college students in Gondar town, northwest Ethiopia, 2018: institutional based cross-sectional study”. BMC Research Notes 11 (2018): 1-6.
32. Bewket Zeleke L., et al. “Utilization of long-acting contraceptive methods and associated factors among female health care providers in East Gojjam Zone, Northwest Ethiopia, in 2018”. BioMed Research International (2019): 1-7.
33. Abdu Muhammed M and Abdo R. “Long-acting reversible contraceptive utilization and its associated factors among family planning users in pastoral communities of Afar Region, Ethiopia: a facility-based cross-sectional study”. Journal of Midwifery and Reproductive Health1 (2020): 2022-2032.
34. Ontiri S., et al. “A qualitative exploration of contraceptive use and discontinuation among women with an unmet need for modern contraception in Kenya”. Reproductive Health1 (2021): 1-0.
35. Ogunjuyigbe PO., et al. “Spousal communication, changes in partner attitude, and contraceptive use among the Yorubas of Southwest Nigeria”. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine2 (2009): 112.
36. Kriel Y., et al. “Male partner influence on family planning and contraceptive use: perspectives from community members and healthcare providers in KwaZulu-Natal, South Africa”. Reproductive Health 1 (2019): 1-5.
37. Bewket Zeleke L., et al. “Utilization of long-acting contraceptive methods and associated factors among female health care providers in East Gojjam Zone, Northwest Ethiopia, in 2018”. BioMed research international (2019).
38. Kraetschmer K. “The Contraceptive Methods Table as Preventive Instrument for Avoiding Abortion”. American Journal of Obstetrics and Gynecological Research 1 (2022):1008.
39. Ramchandran D and Upadhyay UD. “Implants: the next generation”. Population Reports 7 (2007): 1-9.
40. Cleland K., et al. “The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience”. Human Reproduction7 (2012): 1994-2000.
41. Cappello O. “Powerful contraception, complicated programs: preventing coercive promotion of long-acting reversible contraceptives. Guttmacher Policy Review”.
42. Sahiledengle B., et al. “Association between maternal stature and household-level double burden of malnutrition: findings from a comprehensive analysis of Ethiopian Demographic and Health Survey”. Journal of Health, Population and Nutrition1 (2023): 1-6.
43. Kavanaugh ML and Pliskin E. “Use of contraception among reproductive-aged women in the United States, 2014 and 2016”. F and S Reports2 (2020): 83-93.
44. Hibstu DT and Alemayehu A. “Long acting reversible contraceptives utilization and associated factors among women of reproductive age in Arsi Negele town, Southeastern Ethiopia”. Contraception and Reproductive Medicine 1 (2020): 1-7.

Citation

Citation: Daniyal Ahmed. “Factors for the Limited Use of Long-Acting Reversible Contraceptives among Female Health Care Professionals of Reproductive Age in Pakistan's Twin Cities".Acta Scientific Clinical Case Reports 5.6 (2024): 20-25.

Copyright

Copyright: © 2024 Daniyal Ahmed. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.